Ubrelvy — Net revenues
Products & Services · Net revenuesAbbVie Ubrelvy — Net revenues decreased by 4.2% to $339.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.9%, from $303.00M to $339.00M. Over 4 years (FY 2021 to FY 2025), Ubrelvy — Net revenues shows an upward trend with a 23.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market demand, successful commercial execution, or expanded patient access, while a decrease may signal increased competition, patent expirations, or loss of market share.
Detailed definition
This metric represents the total gross sales of a specific pharmaceutical product line after accounting for returns, all...
Peer comparison
Comparable to product-level net sales reported by other biopharmaceutical companies, often categorized under specific therapeutic areas or key growth drivers.
abbv_segment_ubrelvy_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $138.00M | $138.00M | $138.00M | $138.00M | $185.00M | $160.00M | $197.00M | $152.00M | $196.00M | $233.00M | $234.00M | $203.00M | $231.00M | $269.00M | $303.00M | $240.00M | $338.00M | $354.00M | $339.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +34.1% | -13.5% | +23.1% | -22.8% | +28.9% | +18.9% | +0.4% | -13.2% | +13.8% | +16.5% | +12.6% | -20.8% | +40.8% | +4.7% | -4.2% |
| YoY Change | — | — | — | — | +34.1% | +15.9% | +42.8% | +10.1% | +5.9% | +45.6% | +18.8% | +33.6% | +17.9% | +15.5% | +29.5% | +18.2% | +46.3% | +31.6% | +11.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's ubrelvy — net revenues?
- AbbVie (ABBV) reported ubrelvy — net revenues of $339.00M in Q4 2025.
- How has AbbVie's ubrelvy — net revenues changed year-over-year?
- AbbVie's ubrelvy — net revenues increased by 11.9% year-over-year, from $303.00M to $339.00M.
- What is the long-term trend for AbbVie's ubrelvy — net revenues?
- Over 4 years (2021 to 2025), AbbVie's ubrelvy — net revenues has grown at a 23.2% compound annual growth rate (CAGR), from $552.00M to $1.27B.
- What does ubrelvy — net revenues mean?
- The total net sales generated by a specific pharmaceutical product.